Glaucoma patients may get Long-Lasting pressure relief from tiny eye implant
NCT ID NCT06066645
First seen Jan 28, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This study tests whether adding a tiny travoprost-releasing implant (iDose TR) to an existing drainage implant (iStent infinite) lowers eye pressure better than the drainage implant alone. About 230 adults with open-angle glaucoma or high eye pressure will be followed for 12 months. The goal is to see if the combination provides better pressure control without needing daily eye drops.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA OPEN-ANGLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Glaukos Clinical Study Site
RECRUITINGColorado Springs, Colorado, 80907, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.